{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T08:52:08Z","timestamp":1772527928383,"version":"3.50.1"},"reference-count":52,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2016,7,14]],"date-time":"2016-07-14T00:00:00Z","timestamp":1468454400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0158779","type":"journal-article","created":{"date-parts":[[2016,7,14]],"date-time":"2016-07-14T16:30:52Z","timestamp":1468513852000},"page":"e0158779","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":39,"title":["Fluorinated Cannabidiol Derivatives: Enhancement of Activity in Mice Models Predictive of Anxiolytic, Antidepressant and Antipsychotic Effects"],"prefix":"10.1371","volume":"11","author":[{"given":"Aviva","family":"Breuer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christeene G.","family":"Haj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manoela V.","family":"Foga\u00e7a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felipe V.","family":"Gomes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole Rodrigues","family":"Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo\u00e3o Francisco","family":"Pedrazzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elaine A.","family":"Del Bel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaime C.","family":"Hallak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 A.","family":"Crippa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio W.","family":"Zuardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6122-5698","authenticated-orcid":true,"given":"Raphael","family":"Mechoulam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco S.","family":"Guimar\u00e3es","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2016,7,14]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1021\/ja01858a058","article-title":"Structure of cannabidiol, a product isolated from the marijuana extract of Minnesota wild hemp","volume":"62","author":"R Adams","year":"1940","journal-title":"J Am Chem Soc"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1039\/jr9400000649","article-title":"Cannabis indica. Part II. Isolation of cannabidiol from Egyptian hashish. Observations on the structure of cannabinol","author":"A Jacob","year":"1940","journal-title":"J Chem Soc"},{"key":"ref3","first-page":"2073","article-title":"The structure of cannabidiol","volume":"19","author":"R Mechoulam","year":"1963","journal-title":"Tetrahedron"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/S0040-4039(00)90646-4","article-title":"The absolute configuration of \u0394<sup>1<\/sup>-tetrahydrocannabinol, the major active constituent of hashish","author":"R Mechoulam","year":"1967","journal-title":"Tetrahedron Lett"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"11S","DOI":"10.1002\/j.1552-4604.2002.tb05998.x","article-title":"Cannabidiol: An overview of some pharmacological aspects","volume":"42","author":"R Mechoulam","year":"2002","journal-title":"J Clin Pharmacol"},{"key":"ref6","first-page":"1678","article-title":"Cannabidiol\u2014recent advances","volume":"2007","author":"R Mechoulam","journal-title":"Chem Biodivers"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"529","DOI":"10.3390\/ph5050529","article-title":"Cannabidiol in humans\u2014The quest for therapeutic targets","volume":"5","author":"S Zhornitsky","year":"2012","journal-title":"Pharmaceuticals (Basel)"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"3364","DOI":"10.1098\/rstb.2011.0389","article-title":"Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders","volume":"367","author":"AC Campos","year":"2012","journal-title":"Phil Trans R Soc Lond B Biol Sci"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1365-2125.2012.04341.x","article-title":"Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid?","volume":"75","author":"J Fern\u00e1ndez-Ruiz","year":"2013","journal-title":"Br J Clin Pharmacol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"5160","DOI":"10.1523\/JNEUROSCI.3387-15.2016","article-title":"Cannabidiol counteracts amphetamine-induced neuronal and behavioral sensitization of the mesolimbic dopamine pathway through a novel mTOR\/p70S6 kinase signaling pathway","volume":"4","author":"J Renard","year":"2016","journal-title":"J Neurosci"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1159\/000137430","article-title":"Chronic administration of CBD to healthy volunteers and epileptic patients","volume":"21","author":"JM Cunha","year":"1980","journal-title":"Pharmacology"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.seizure.2016.01.004","article-title":"CBD-enriched medical cannabis for intractable pediatric epilepsy: The current Israeli experience","volume":"35","author":"M Tzadok","year":"2016","journal-title":"Seizure"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/S1474-4422(15)00379-8","article-title":"Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial","volume":"15","author":"O Devinsky","year":"2016","journal-title":"Lancet Neurol"},{"key":"ref14","first-page":"270","article-title":"Cannabidiol for epilepsy:trying to see through the haze","volume":"15","author":"K Detynecki","year":"2016","journal-title":"Lancet Neurol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/BF00432554","article-title":"Action of cannabidiol on the anxiety and other effects produced by delta 9-THC in normal subjects","volume":"76","author":"AW Zuardi","year":"1982","journal-title":"Psychopharmacology (Berl)"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1007\/BF02244189","article-title":"Effects of cannabidiol in animal models predictive of antipsychotic activity","volume":"104","author":"AW Zuardi","year":"1991","journal-title":"Psychopharmacology (Berl)"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ejphar.2005.02.040","article-title":"Cannabidiol inhibits hyperlocomotion induced by psychotomimetic drugs in mice","volume":"512","author":"FA Moreira","year":"2005","journal-title":"Eur J Pharmacol"},{"key":"ref18","first-page":"1","article-title":"Cannabidiol attenuates sensorimotor gating disruption and molecular changes induced by chronic antagonism of NMDA receptors in mice","volume":"18","author":"FV Gomes","year":"2014","journal-title":"Int J Neuropsychopharmacol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.1007\/s00213-015-3945-7","article-title":"Cannabidiol effects in the prepulse inhibition disruption induced by amphetamine","volume":"232","author":"JF Pedrazzi","year":"2015","journal-title":"Psychopharmacology (Berl)"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s13311-015-0387-1","article-title":"Cannabidiol as a potential treatment for anxiety disorders","volume":"12","author":"EM Blessing","year":"2015","journal-title":"Neurotherapeutics"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0306-3623(94)90027-2","article-title":"Anxiolytic effect of cannabidiol derivatives in the elevated plus-maze","volume":"25","author":"FS Guimaraes","year":"1994","journal-title":"General Pharmacol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1017\/S1461145712001502","article-title":"The anxiolytic effect of cannabidiol on chronically stressed mice depends on hippocampal neurogenesis: involvement of the endocannabinoid system","volume":"16","author":"AC Campos","year":"2013","journal-title":"Int J Neuropsychopharmacol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/npp.2011.6","article-title":"Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-na\u00efve social phobia patients","volume":"36","author":"MM Bergamaschi","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1476-5381.2009.00521.x","article-title":"Antidepressant-like effects of cannabidiol in mice: possible involvement of 5-HT1A receptors","volume":"159","author":"TV Zanelati","year":"2010","journal-title":"Br J Pharmacol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/FBP.0b013e32833b33c5","article-title":"Cannabidiol inhibitory effect on marble-burying behaviour: involvement of CB1 receptors","volume":"21","author":"PC Casarotto","year":"2010","journal-title":"Behav Pharmacol"},{"key":"ref26","first-page":"485","article-title":"Antipsychotic effect of cannabidiol","volume":"56","author":"AW Zuardi","year":"1995","journal-title":"J Clin Psychiatry"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1177\/0269881106060967","article-title":"Cannabidiol monotherapy for treatment-resistant schizophrenia","volume":"20","author":"AW Zuardi","year":"2006","journal-title":"J Psychopharmacol"},{"key":"ref28","first-page":"1","article-title":"Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia","volume":"2","author":"FM Leweke","year":"2012","journal-title":"Transl Psych"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1586\/14737175.2015.1067607","article-title":"Effect of Sativex on spasticity-associated symptoms in patients with multiple sclerosis","volume":"15","author":"SG Meuth","year":"2015","journal-title":"Expert Rev Neurother"},{"key":"ref30","article-title":"Bioorganic and Medicinal Chemistry of Fluorine","author":"JP Begue","year":"2008"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1126\/science.1131943","article-title":"Fluorine in pharmaceuticals:looking beyond intuition","volume":"317","author":"K Muller","year":"2007","journal-title":"Science"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1021\/ja00730a036","article-title":"The isolation and structure of \u0394<sup>1<\/sup>-THC and other neutral cannabinoids from hashish","volume":"93","author":"Y Gaoni","year":"1971","journal-title":"J Am Chem Soc"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/cbdd.12637","article-title":"HU-446 and HU-465, derivatives of the non-psychoactive cannabinoid cannabidiol, decrease the activation of encephalitogenic T cells","volume":"87","author":"E Kozela","year":"2016","journal-title":"Chem Biol Drug Des"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.pnpbp.2010.11.027","article-title":"Facilitation of CB1 receptor-mediated neurotransmission decreases marble burying behavior in mice","volume":"35","author":"FV Gomes","year":"2011","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.bbalip.2008.10.007","article-title":"Endocannabinoid Research Group. Development of a potent inhibitor of 2-arachidonoylglycerol hydrolysis with antinociceptive activity in vivo","volume":"1791","author":"T Bisogno","year":"2009","journal-title":"Biochim Biophys Acta"},{"key":"ref36","first-page":"25","article-title":"In Experimental Approaches to Anxiety and Depression","author":"SE File","year":"1992"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0091-3057(91)90590-X","article-title":"Evaluation of marble-burying behavior as a model of anxiety","volume":"38","author":"K Njung'e","year":"1991","journal-title":"Pharmacol Biochem Behav"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"8563","DOI":"10.1021\/ja00179a047","article-title":"Power- and structure-variable fluorinating agents. The N-fluoropyridinium salt system","volume":"112","author":"T Umemoto","year":"1990","journal-title":"J Am Chem Soc"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1080\/00397918408063751","article-title":"A procedure for the conversion of cannabidiol into 12\u03b2-Substituted tetrahydrocannabinols (THC&apos;s): Synthesis of 12\u03b2-Hydroxy-\u03949 -THC","volume":"14","author":"VS Jorapur","year":"1984","journal-title":"Synth Commun"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0022-1139(98)00115-8","article-title":"Substituent effects on the regioselectivity in fluorination of allylic alcohols with DAST","volume":"88","author":"A Boukerb","year":"1998","journal-title":"J Fluor Chem"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00504983","article-title":"Effects of alpha-adrenoceptor agonists and antagonists in a maze-exploration model of &apos;fear&apos;-motivated behaviour","volume":"327","author":"SL Handley","year":"1984","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"S101","DOI":"10.1590\/1516-4446-2013-1139","article-title":"Animal models of anxiety disorders and stress","volume":"35","author":"AC Campos","year":"2013","journal-title":"Rev Bras Psiquiatr"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1007\/BF02244012","article-title":"Antianxiety effect of cannabidiol in the elevated plus-maze","volume":"100","author":"FS Guimar\u00e3es","year":"1990","journal-title":"Psychopharmacology (Berl)"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.pbb.2005.01.029","article-title":"Endocannabinoid system and stress and anxiety responses","volume":"81","author":"MP Viveros","year":"2005","journal-title":"Pharmacol Biochem Behav"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0165-6147(02)02017-5","article-title":"Assessing antidepressant activity in rodents: recent developments and future needs","volume":"23","author":"JF Cryan","year":"2002","journal-title":"Trends Pharmacol Sci"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/266730a0","article-title":"Depression: a new animal model sensitive to antidepressant treatments","volume":"266","author":"RD Porsolt","year":"1977","journal-title":"Nature"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.neuropharm.2015.12.017","article-title":"Cannabidiol induces rapid-acting antidepressant-like effects and enhances cortical 5-HT\/glutamate neurotransmission: Role of 5-HT1A receptors","volume":"103","author":"R Linge","year":"2016","journal-title":"Neuropharmacology"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s002130100811","article-title":"Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review","volume":"156","author":"MA Geyer","year":"2001","journal-title":"Psychopharmacology (Berl)"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/00008877-200006000-00002","article-title":"Animal models of deficient sensorimotor gating: what we know, what we think we know, and what we hope to know soon","volume":"11","author":"NR Swerdlow","year":"2000","journal-title":"Behav Pharmacol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1038\/sj.npp.1300838","article-title":"Cannabidiol reverses MK-801-induced disruption of prepulse inhibition in mice","volume":"31","author":"LE Long","year":"2006","journal-title":"Neuropsychopharmacol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s00213-009-1466-y","article-title":"Marble burying reflects a repetitive and perseverative behavior more than novelty-induced anxiety","volume":"204","author":"A Thomas","year":"2009","journal-title":"Psychopharmacology (Berl)"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1038\/npp.2012.63","article-title":"On disruption of fear memory by reconsolidation blockade: evidence from cannabidiol treatment","volume":"37","author":"CA Stern","year":"2012","journal-title":"Neuropsychopharmacol"}],"updated-by":[{"DOI":"10.1371\/journal.pone.0162087","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2016,8,25]],"date-time":"2016-08-25T00:00:00Z","timestamp":1472083200000}}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0158779","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T23:03:38Z","timestamp":1540335818000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0158779"}},"subtitle":[],"editor":[{"given":"Tiziana","family":"Rubino","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2016,7,14]]},"references-count":52,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2016,7,14]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0158779","relation":{"correction":[{"id-type":"doi","id":"10.1371\/journal.pone.0162087","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,14]]}}}